COMMUNIQUÉS West-GlobeNewswire

Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2019
04/06/2019
Paris, le 3 juin 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de façon [...]
New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019
04/06/2019
- Several scientific conference contributions outline benefits of U.S. FDA-cleared Unyvero LRT Application Cartridge in both endotracheal aspirate and bronchoalveolar lavage samples - Study shows that Unyvero LRT has [...]
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL
04/06/2019
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL Biopharmaceutical veteran Edwina Baskin-Bey, M.D., joins Nanobiotix as its new Chief Medical Officer ( [...]
Nanobiotix nomme un nouveau directeur médical à la suite de son autorisation de mise sur le marché européen
04/06/2019
NANOBIOTIX NOMME UN NOUVEAU DIRECTEUR M É DICAL À LA SUITE DE SON AUTORISATION DE MISE SUR LE MARCH É EUROP É EN Experte de l’industrie Biopharmaceutique, le Dr. Edwina Baskin-Bey rejoint Nanobiotix en tant que nouveau [...]
OV’s method can predict if neoadjuvant treatment with doxorubicin in breast cancer will be successful, data published in ASCO journal
04/06/2019
Investor News Hoersholm, Denmark and Cambridge, MA, US, June 4, 2019. – Oncology Venture A/S (“OV” or “the Company”) today announced that an e-abstract has been published in Journal of Clinical Oncology – an ASCO [...]
Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD
04/06/2019
Ensifentrine delivery via MDI inhalers could dramatically expand clinical utility and commercial opportunity LONDON, June 04, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a [...]
ObsEva SA Announces Completion of Patient Recruitment in IMPLANT 4 Phase 3 Clinical Trial of Nolasiban for Improving IVF Outcomes
04/06/2019
Geneva, Switzerland and Boston, MA – June 4, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Sequana Medical Announces Unconditional IDE Approval from U.S. FDA to Start alfapump® Pivotal Study (POSEIDON)
04/06/2019
alfa pump pivotal study for treatment of recurrent or refractory ascites due to liver cirrhosis Optimised clinical trial design of up to 50 patients implanted with alfa pump in study cohort and shorter follow-up time [...]
MedMira Announces AGM Results
04/06/2019
HALIFAX, Nova Scotia, June 03, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) held its 2019 Annual General Meeting of Shareholders on May 31, 2019 in Halifax, Nova Scotia. Incumbent Director Mr. Hermes Chan [...]
Veloxis Increases Share Capital in Connection with Exercise of Warrants
03/06/2019
Company Release no. 10/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 June 2019 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company's [...]
National Research Corporation Declares Quarterly Dividend
03/06/2019
Lincoln, Nebraska, June 03, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 (nineteen cents) per share [...]
Adamas to Present at Upcoming JMP Investor Conference
03/06/2019
EMERYVILLE, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]
Meridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOC
03/06/2019
CINCINNATI, June 03, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has completed its previously [...]
Meeting of Holders of Debentures Issued by Golden Leaf Holdings to be Held
03/06/2019
TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis company built around recognized brands for the wellness and recreational markets [...]
Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference
03/06/2019
BERKELEY, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), today announced that Ryan Spencer, Senior Vice President, Commercial, and Interim Co-President, will present at the [...]
Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers
03/06/2019
- SRK-015 was well-tolerated in healthy volunteers across all tested doses, supporting evaluation in the ongoing Phase 2 TOPAZ trial in Spinal Muscular Atrophy (SMA) - Pharmacodynamic results from the completed multiple [...]
Sientra Commences Public Offering of Common Stock
03/06/2019
SANTA BARBARA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that it has commenced an underwritten public follow-on [...]
Oncternal Therapeutics Announces Updated Interim Data from a Phase 1/2 Study of Cirmtuzumab in Combination with Ibrutinib
03/06/2019
Data presented today at the 2019 American Society of Clinical Oncology Annual Meeting SAN DIEGO, June 03, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., a clinical-stage biotechnology company focused on [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
03/06/2019
COPENHAGEN, Denmark, June 3, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on May 22, 2019, has now been terminated, as the intended [...]

Pages